Annovis Bio, Inc. (ANVS)
| Market Cap | 116.65M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.28M |
| Shares Out | 8.10M |
| EPS (ttm) | -1.40 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 107,710 |
| Open | 15.19 |
| Previous Close | 15.52 |
| Day's Range | 14.10 - 15.48 |
| 52-Week Range | 9.71 - 132.00 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 70.00 (+386.1%) |
| Earnings Date | Nov 3, 2021 |
About ANVS
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. T...
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for Annovis Bio stock is "Buy" and the 12-month stock price forecast is 70.00.
News
Annovis Bio Enhances Leadership Team with Two Senior Appointments
Company Appoints Eve Damiano, MS, RAC, as Senior Vice President of Regulatory OperationsCompany Promotes Cheng Fang, Ph.D., to Senior Vice President of Research & DevelopmentBerwyn, Pennsylvania--(Newsf...
Annovis Bio Announces Official Unique Name Buntanetap for Lead Candidate ANVS401
Berwyn, Pennsylvania--(Newsfile Corp. - January 5, 2022) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing neurodegenerative diseases, toda...
Annovis Bio to Participate in the Biotech Showcase and H.C. Wainwright Bioconnect Virtual Conferences
Company to Conduct Virtual One-on-One Meetings During Biotech ShowcaseBerwyn, Pennsylvania--(Newsfile Corp. - January 3, 2022) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-s...
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
Berwyn, Pennsylvania--(Newsfile Corp. - December 20, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing neurodegenerative dis...
Annovis Bio Announces Publication of ANVS401 Mechanism of Action in Peer-Reviewed Pharmaceutics
ANVS401 (Posiphen) Inhibits the Translation of mRNAs of Neurotoxic Proteins Responsible for the Progression of Neurodegenerative DiseasesBerwyn, Pennsylvania--(Newsfile Corp. - December 14, 2021) - Anno...
Annovis Bio Announces Transfer of Listing to the New York Stock Exchange
Trading to begin November 18, 2021 with current ticker "ANVS"Berwyn, Pennsylvania--(Newsfile Corp. - November 15, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical...
Annovis Bio Presented At The 14th Clinical Trials on Alzheimer's Disease Conference
With additional data, the primary, secondary, and exploratory endpoints were met in Phase 2a studyBerwyn, Pennsylvania--(Newsfile Corp. - November 12, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("A...
Annovis Bio Presents Poster on Mechanism of Action at the 14th Clinical Trials on Alzheimer's Disease (CTAD) Conference
Poster highlighting the mechanism of action for ANVS401 is on display onsite and onlineBerwyn, Pennsylvania--(Newsfile Corp. - November 9, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or t...
SHAREHOLDER ALERT: Robbins LLP Investigates Annovis Bio, Inc. (ANVS) for Misleading Shareholders
SAN DIEGO--(BUSINESS WIRE)---- $ANVS #alzheimersdisease--Annovis Bio, Inc. (ANVS) is Accused of Materially Misrepresented the Outcome of its ANVS401 Clinical Trials
Annovis Bio to Present at the 14th Clinical Trials on Alzheimer's Disease (CTAD) Conference
Dr. Maria Maccecchini will present additional Phase 2 data on November 12, 10:25 a.m. ESTA poster highlighting the mechanism of action for ANVS401 will be on display onsite and onlineBerwyn, Pennsylvani...
SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Annovis Bio, Inc. of Cla...
NEW YORK, Oct. 15, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Annovis Bio, Inc. ("Annovis" or the "Company") (NYSE: ANVS) and certain of its officers...
DEADLINE MONDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and ...
Los Angeles, California--(Newsfile Corp. - October 14, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Annovis Bio, Inc. ...
CLASS ACTION UPDATE for ANVS, HNST and HYZN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Sh...
NEW YORK, NY / ACCESSWIRE / October 13, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholder...
LAWSUITS FILED AGAINST ANVS, EAR and HYZN - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / October 13, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies wh...
Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for Annovis Bio, Inc. Investors in Securities Fraud C...
RADNOR, Pa., Oct. 13, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against Annovis Bio, Inc. (NYS...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Annovis Bio, Inc. of a Class Action Lawsuit and a L...
New York, New York--(Newsfile Corp. - October 13, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of A...
ANVS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Annovis Bio, Inc.
New York, New York--(Newsfile Corp. - October 12, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Annovis Bio, Inc....
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of LIVE, ANVS and SAVA
NEW YORK, NY / ACCESSWIRE / October 12, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. ...
Final Deadline Approaching on October 18, 2021: Kessler Topaz Meltzer & Check, LLP Reminds Annovis Bio, Inc. Investor...
Radnor, Pennsylvania--(Newsfile Corp. - October 12, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis") investors that a securities fra...
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Annovis Bio, Inc. of a Class Action Lawsuit and a Lead...
New York, New York--(Newsfile Corp. - October 12, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Annovis Bio, Inc. (NYSE Ameri...
MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. a...
Los Angeles, California--(Newsfile Corp. - October 12, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Annovis Bio, Inc. ...
ANVS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 18, 2021 in the Class Action Filed on B...
New York, New York--(Newsfile Corp. - October 12, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Annovis Bio, Inc. (NYSE American: ANVS) ...
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SLQT, ANVS and ATIP
NEW YORK, NY / ACCESSWIRE / October 12, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. ...
ANNOVIS BIO Investor Alert: Class Action Lawsuit Filed
Boston, Massachusetts--(Newsfile Corp. - October 11, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Annovis Bio, Inc. (NYSE American:...
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of YALA, LIVE and ANVS
NEW YORK, NY / ACCESSWIRE / October 11, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. ...